Rate of Adriamycin Resistance Associated (ARA) long Noncoding RNA Expression in Sample of Hepatitis B Virus Iraqi Patients
Main Article Content
Abstract
Numerous biological processes, including epigenetics regulation, control of cell cycle, beside transcriptional, translational and regulation of genes expression, have been linked to long non-coding RNAs lncRNAs . the disruption of expression for lncRNAs are important early stages in in hepatitis B virus disease.
Objectives: In order to investigate ARA lncRNA production in Hepatitis B patients, analyze its clinical importance, and examine the possible value as a predictive biomarker, Amplification of Adriamycin Resistance Associated Lnc-RNA and Glyceraldehyde 3-phosphate dehydrogenase (reference gene) was done by two steps reverase- transcriptase polymerase chain reaction ,No significant difference P = 0.566 was observed in the Adriamycin Resistance Associated lncRNA serum levels between chronic hepatitis B virus patient and control ,In the patients group with chronic HBV )infection, the expression of Adriamycin Resistance Associated lncRNAs was elevated to the 2 fold.
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
- Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral research. 2020; 182:104925. DOI: https://doi.org/10.1016/j.antiviral.2020.104925
- al-Tamimi AA.Prevalence of Hepatitis B virus infection in al-Taji district. Al- Mustansiriyah J. Sci. 2013;24(2):25–30.
- Maral F T, Mohammed H. A, Nazar M A, Knowledge About Hepatitis B Infection Among Undergraduate Medical and Health College Students, Baghdad. Mustansiriya Medical Journal201. 2017;16(2):63–67. DOI: https://doi.org/10.4103/2070-1128.251020
- Samulin Erdem J, Notø H, Skare. Mechanisms of breast cancer risk in shift workers: association of telomere short-ening with the duration and intensity of night work. Cancer Med. 2017; 6:1988–1997. DOI: https://doi.org/10.1002/cam4.1135
- Gibb EA. Brown CJ. Lam WL. The functional role of long non-cod-ing RNA in human carcinomas. Mol Cancer. 2011; 10:38. DOI: https://doi.org/10.1186/1476-4598-10-38
- Agliano F, Rathinam VA, Medvedev AE, Vanaja SK, Vella AT. Long noncoding RNAs in host–pathogen interactions. Trends Immunol. 2019;40(6):492–510. DOI: https://doi.org/10.1016/j.it.2019.04.001
- Yilmaz Susluer S, Kayabasi C, Ozmen Yelken B. Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients. Bosn J Basic Med Sci. 2018;18(2):150–61. DOI: https://doi.org/10.17305/bjbms.2018.2800
- Liu Y, Feng J, Sun M, et al. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer Lett. 2019; 454:158–70. DOI: https://doi.org/10.1016/j.canlet.2019.04.008
- Malhotra A, Jain M, Prakash H, et al. The regulatory roles of long non-coding RNAs in the development of chemoresist-ance in breast cancer. Oncotarget . 2017; 8:110671–110684. DOI: https://doi.org/10.18632/oncotarget.22577
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–∆∆CT method. Methods. 2001; 25:402–408. DOI: https://doi.org/10.1006/meth.2001.1262
- Kadham, M. Precore and Basal Core Promoter mutations of chronic Hepatitis B virus in relation to drug resistance chronic infections in some Iraqi. 2018. Ph.D. Thesis, College of Science. University of Mustansiriyai.
- Mak LY, Seto WK, Fung J, Yuen MF. Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B. Hepatology International. 2020; 14:35-46. DOI: https://doi.org/10.1007/s12072-019-09998-5
- Chan H.L., Tse C.H., Mo F., Koh J., Wong V.W., Wong G.L., et al. 2008.High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.J Clin Oncol, 26 . pp. 177-182. DOI: https://doi.org/10.1200/JCO.2007.13.2043
- Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., 2006.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA, 295 . pp. 65-73. DOI: https://doi.org/10.1001/jama.295.1.65
- Kondo Y, Shinjo K, Katsushima K. Long non-coding RNAs as an epigenetic regulator in human cancers. Cancer Sci .2017;108:1927–1933. DOI: https://doi.org/10.1111/cas.13342
- Farzaneh R, Mahdieh A, Raheleh A, Sara I, Esmat N, Arvand A,Esmaeil M, Mansoor K,Asghar A.ARA lncRNA, is upregulated in liver and breast tumor tissues, Molecular Biology Reports . 2018; 11033-018-4447-6
- Sunde Y, Cagla K, Besra O, Aycan A, Didem C, Tugce B, Suheyla S, Cigir B, Sukran K, Cumhur G.Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients Bosn J Basic Med Sci. 2018;18(2):150-161. DOI: https://doi.org/10.17305/bjbms.2018.2800
- Jiang, Min. "A novel long non-coding RNA-ARA: adriamycin resistance associated." Biochemical pharmacology. 2014; 87.2. 254-283. DOI: https://doi.org/10.1016/j.bcp.2013.10.020
- M.B. Melixetian. Altered expression of DNA-topoisomerase IIalpha is associated with increased rate of spontaneous polyploidization in etoposide resistant K562 cells. Leukemia Research.2000; 24(10): 831-83 DOI: https://doi.org/10.1016/S0145-2126(00)00054-0
- F. Wang. A non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Letters. 2008; 582(13):1919-1927 DOI: https://doi.org/10.1016/j.febslet.2008.05.012
- Ramnarine VR, Kobelev M, Gibb EA. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. Eur Urol. 2019;76(5):546–59. DOI: https://doi.org/10.1016/j.eururo.2019.07.040
- Zhang L, Meng X, Zhu XW. Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer .2019;18(1):102. DOI: https://doi.org/10.1186/s12943-019-1021-3
- Li C, Chen J, Zhang K, Feng B, Wang R, Chen L. Progress and prospects of long noncoding RNAs (lncRNAs) in hepatocellular carcinoma. Cellular Physiology and Biochemistry. 2015;36(2):423-34. DOI: https://doi.org/10.1159/000430109
- Unfried JP, Sangro P, Prats-Mari L, Sangro B, Fortes P. The landscape of lncRNAs in hepatocellular carcinoma: a translational perspective. Cancers. 2021 28;13(11):2651. DOI: https://doi.org/10.3390/cancers13112651
- Matin F, Jeet V, Moya L. A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer. Sci Rep. 2018;8(1):6653. DOI: https://doi.org/10.1038/s41598-018-24424-w
